Abstract | OBJECTIVE & AIM: The coronavirus disease, so far (COVID-19) has brought about millions of infections and fatalities throughout the world. Our aim was to determine the correlation between rubella IGG titers with the severity COVID-19. MATERIALS & METHODS: This study was conducted among COVID-19 confirmed patients over 18 years of age. The disease severity levels were categorized by WHO interim guidance. The rubella-specific IgG antibody-titer spectrum was measured (within first 48 h of hospitalization) by enzyme-linked immunosorbent assay (ELISA). RESULT: In a study of 46 inpatients with varying COVID-19 disease severity (mild, moderate, severe, and critical), we observed a negative correlation between rubella IgG antibody titers and COVID-19 severity (P-Value = 0.017), There was an interaction between COVID-19 vaccination history and rubella IGG on severity COVID-19 (P-Value = 0.0015). There was an interaction between age group under 44 years (including national measles- rubella (MR) vaccination in Iran) and rubella IGG titers on severity COVID-19 too (p-value = 0.014). CONCLUSION: In conclusion, MR vaccination seems to have a positive effect in reducing the severity of the disease, emphasizing that, the important and separate effect of the IGG rubella (due to natural or extrinsic immunity) titers is determining.
|
Authors | Leyla Sahebi, Mohsen Hosseini, Alireza Abdollahi, Nahid Farrokhzad, Samrand Fattah Ghazi, Farzaneh Samaei Noroozi, Fereshteh Ghiasvand |
Journal | BMC microbiology
(BMC Microbiol)
Vol. 22
Issue 1
Pg. 156
(06 11 2022)
ISSN: 1471-2180 [Electronic] England |
PMID | 35690730
(Publication Type: Journal Article)
|
Copyright | © 2022. The Author(s). |
Chemical References |
- Antibodies, Viral
- COVID-19 Vaccines
- Immunoglobulin G
|
Topics |
- Adolescent
- Adult
- Antibodies, Viral
- COVID-19
- COVID-19 Vaccines
- Enzyme-Linked Immunosorbent Assay
- Humans
- Immunoglobulin G
- Rubella
|